Thrivent Financial for Lutherans Takes Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Thrivent Financial for Lutherans bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 79,536 shares of the company's stock, valued at approximately $588,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Cibc World Markets Corp bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $96,000. First Eagle Investment Management LLC lifted its holdings in LifeStance Health Group by 182.8% during the fourth quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock worth $5,790,000 after buying an additional 507,826 shares during the period. AlphaQuest LLC bought a new stake in LifeStance Health Group during the 4th quarter valued at $340,000. Keybank National Association OH increased its holdings in shares of LifeStance Health Group by 86.4% in the 4th quarter. Keybank National Association OH now owns 56,974 shares of the company's stock valued at $420,000 after acquiring an additional 26,412 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of LifeStance Health Group by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company's stock worth $8,206,000 after acquiring an additional 9,046 shares in the last quarter. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Stock Up 0.3 %

NASDAQ LFST traded up $0.02 during trading on Tuesday, hitting $6.53. The company's stock had a trading volume of 3,324,027 shares, compared to its average volume of 1,587,006. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The company has a market cap of $2.51 billion, a PE ratio of -25.12 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The business's 50 day simple moving average is $7.37 and its 200-day simple moving average is $7.34.

Remove Ads

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 6.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on LFST shares. William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target on the stock. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a research note on Monday, December 16th. Finally, KeyCorp initiated coverage on shares of LifeStance Health Group in a research report on Tuesday. They set an "overweight" rating and a $9.00 target price for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $8.58.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.